Kerecis Fish Skin Grafts With and Without Platelet Rich Plasma (PRP)
Non-healing Wound
About this trial
This is an interventional treatment trial for Non-healing Wound focused on measuring xenograft, PRP, platelet rich plasma
Eligibility Criteria
Inclusion Criteria: Patient is over the age of 18 years; The targeted wound is deemed a chronic, nonhealing wound after six weeks of treatment; - - Patient of Dr. Eldridge, Dr. Glenn, or Dr. Worley; Target wound size must be between 2 cm x 2 cm x 0.1 cm deep and 10 cm x 10 cm x 5 cm deep; Surgical candidate for standard of care Kerecis® xenograft surgery. Exclusion Criteria: Patient with hemoglobin values less than 6.9 g/dL drawn at least 30 days prior to the Kerecis® xenograft surgery; Patient with a known allergy or other sensitivity to fish material; Patient is currently undergoing chemotherapy or radiation therapy; The targeted wound is of autoimmune origin; and Non-English-speaking patients.
Sites / Locations
- St. Elizabeth Healthcare Edgewood
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Xenograft only
Xenograft and PRP
The Kerecis® xenograft (Kerecis® Omega3 MariGen) will be applied without the application of PRP.
The Kerecis® xenograft (Kerecis® Omega3 MariGen) will be applied with the application of PRP.